DARATUMUMAB (DARA), CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE FOR TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TE NDMM) PATIENTS: RESPONSE RATE IMPACTS ON PFS
| Autor: | EQ Crusoé, JSLRD Santos, JAD Santos, HHM Santos, AS Santos, LF Lucas, AM Almeida, VT Hungria, MA Salvino, MGB Arruda |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Hematology, Transfusion and Cell Therapy. 44:S267 |
| ISSN: | 2531-1379 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|